CUPR is trading 47.5% up at $5.81 in pre-market, driven by the announcement of 510(k) clearance from the FDA for its MEDIFLY Maggots. - This significant development follows recent volatility and the company regaining Nasdaq compliance on June 11, 2026. - The broader cryptocurrency market, in contrast, shows a mixed to negative sentiment today.